# `isb-cgc-bq.HTAN_versioned.clinical_tier1_followup_r3_v2.md`

## Column details

* [STRING]    `Component`
  - Category of metadata (e.g. Diagnosis, Biospecimen, scRNA-seq Level 1, etc.); provide the same one for all items/rows.
* [STRING]    `HTAN_Participant_ID`
  - HTAN ID associated with a patient based on HTAN ID SOP (eg HTANx_yyy )
* [STRING]    `Days_to_Follow_Up`
  - Number of days between the date used for index and the date of the patient's last follow-up appointment or contact. If not applicable please enter 'Not Applicable'
* [STRING]    `Adverse_Event`
  - Text that represents the Common Terminology Criteria for Adverse Events low level term name for an adverse event.
* [STRING]    `Progression_or_Recurrence`
  - Yes/No/unknown indicator to identify whether a patient has had a new tumor event after initial treatment.
* [STRING]    `Barretts_Esophagus_Goblet_Cells_Present`
  - Presence or absennce of Barretts esophagus goblet cells.
* [STRING]    `BMI`
  - A calculated numerical quantity that represents an individual's weight to height ratio.
* [STRING]    `Cause_of_Response`
  - The text term used to describe the suspected cause or reason for the patient disease response.
* [STRING]    `Comorbidity`
  - The text term used to describe a comorbidity disease, which coexists with the patient's malignant disease.
* [STRING]    `Comorbidity_Method_of_Diagnosis`
  - The text term used to describe the method used to diagnose the patient's comorbidity disease.
* [STRING]    `Days_to_Adverse_Event`
  - Number of days between the date used for index and the date of the patient's adverse event. If not applicable please enter 'Not Applicable'
* [STRING]    `Days_to_Comorbidity`
  - Number of days between the date used for index and the date the patient was diagnosed with a comorbidity. If not applicable please enter 'Not Applicable'
* [STRING]    `Diabetes_Treatment_Type`
  - Text term used to describe the types of treatment used to manage diabetes.
* [STRING]    `Disease_Response`
  - Code assigned to describe the patient's response or outcome to the disease.
* [STRING]    `DLCO_Ref_Predictive_Percent`
  - The value, as a percentage of predicted lung volume, measuring the amount of carbon monoxide detected in a patient's lungs.
* [STRING]    `ECOG_Performance_Status`
  - The ECOG functional performance status of the patient/participant.
* [STRING]    `FEV1_FVC_Post_Bronch_Percent`
  - Percentage value to represent result of Forced Expiratory Volume in 1 second (FEV1) divided by the Forced Vital Capacity (FVC) post-bronchodilator.
* [STRING]    `FEV_1_FVC_Pre_Bronch_Percent`
  - Percentage value to represent result of Forced Expiratory Volume in 1 second (FEV1) divided by the Forced Vital Capacity (FVC) pre-bronchodilator.
* [STRING]    `FEV1_Ref_Post_Bronch_Percent`
  - The percentage comparison to a normal value reference range of the volume of air that a patient can forcibly exhale from the lungs in one second post-bronchodilator.
* [STRING]    `FEV1_Ref_Pre_Bronch_Percent`
  - The percentage comparison to a normal value reference range of the volume of air that a patient can forcibly exhale from the lungs in one second pre-bronchodilator.
* [STRING]    `Height`
  - The height of the patient in centimeters.
* [STRING]    `Hepatitis_Sustained_Virological_Response`
  - The yes/no/unknown indicator used to describe whether the patient received treatment for a risk factor the patient had at the time of or prior to their diagnosis.
* [STRING]    `HPV_Positive_Type`
  - Text classification to represent the strain or type of human papillomavirus identified in an individual.
* [STRING]    `Karnofsky_Performance_Status`
  - Text term used to describe the classification used of the functional capabilities of a person.
* [STRING]    `Menopause_Status`
  - Text term used to describe the patient's menopause status.
* [STRING]    `Pancreatitis_Onset_Year`
  - Date of onset of pancreatitis.
* [STRING]    `Reflux_Treatment_Type`
  - Text term used to describe the types of treatment used to manage gastroesophageal reflux disease (GERD).
* [STRING]    `Risk_Factor`
  - The text term used to describe a risk factor the patient had at the time of or prior to their diagnosis.
* [STRING]    `Risk_Factor_Treatment`
  - The yes/no/unknown indicator used to describe whether the patient received treatment for a risk factor the patient had at the time of or prior to their diagnosis.
* [STRING]    `Viral_Hepatitis_Serologies`
  - Text term that describes the kind of serological laboratory test used to determine the patient's hepatitus status.
* [STRING]    `Weight`
  - The weight of the patient measured in kilograms.
* [STRING]    `Adverse_Event_Grade`
  - The text term used to describe a specific histone variants, which are proteins that substitute for the core canonical histones.
* [STRING]    `AIDS_Risk_Factors`
  - The text term used to describe a risk factor of the acquired immunodeficiency syndrome (AIDS) that the patient either had at time time of the study or experienced in the past.
* [STRING]    `Body_Surface_Area`
  - Numeric value used to represent the 2-dimensional extent of the body surface relating height to weight.
* [STRING]    `CD4_Count`
  - The text term used to describe the outcome of the procedure to determine the amount of the CD4 expressing cells in a sample.
* [STRING]    `CDC_HIV_Risk_Factors`
  - The text term used to describe a risk factor for human immunodeficiency virus, as described by the Center for Disease Control.
* [STRING]    `Days_to_imaging`
  - Number of days between the date used for index and the date the imaging or scan was performed on the patient. If not applicable please enter 'Not Applicable'
* [STRING]    `Evidence_of_Recurrence_Type`
  - The text term used to describe the type of evidence used to determine whether the patient's disease recurred
* [STRING]    `HAART_Treatment_Indicator`
  - The text term used to indicate whether the patient received Highly Active Antiretroviral Therapy (HAART).
* [STRING]    `HIV_Viral_Load`
  - Numeric value that represents the concentration of an analyte or aliquot extracted from the sample or sample portion, measured in milligrams per milliliter.
* [STRING]    `Hormonal_Contraceptive_Use`
  - The text term used to indicate whether the patient used hormonal contraceptives.
* [STRING]    `Hysterectomy_Margins_Involved`
  - The text term used to indicate whether the patient's disease was determined to be involved based on the surgical margins of the hysterectomy.
* [STRING]    `Hysterectomy_Type`
  - The text term used to describe the type of hysterectomy the patient had.
* [STRING]    `Imaging_Result`
  - The text term used to describe the result of the imaging or scan performed on the patient.
* [STRING]    `Imaging_Type`
  - The text term used to describe the type of imaging or scan performed on the patient.
* [STRING]    `Immunosuppressive_Treatment_Type`
  - The text term used to describe the type of immunosuppresive treatment the patient received.
* [STRING]    `Nadir_CD4_Count`
  - Numeric value that represents the lowest point to which the CD4 count has dropped (nadir).
* [STRING]    `Pregnancy_Outcome`
  - The text term used to describe the type of pregnancy the patient had
* [STRING]    `Recist_Targeted_Regions_Number`
  - Numeric value that represents the number of baseline target lesions, as described by the Response Evaluation Criteria in Solid Tumours (RECIST) criteria
* [STRING]    `Recist_Targeted_Regions_Sum`
  - Numeric value that represents the sum of baseline target lesions, as described by the Response Evaluation Criteria in Solid Tumours (RECIST) criteria.
* [STRING]    `Scan_Tracer_Used`
  - The text term used to describe the type of tracer used during the imaging or scan of the patient.
* [STRING]    `Days_to_Recurrence`
  - Number of days between the date used for index and the date the patient's disease recurred. If not applicable please enter 'Not Applicable'
* [STRING]    `Progression_or_Recurrence_Anatomic_Site`
  - The text term used to describe the anatomic site of resection; biopsy; tissue or organ of biospecimen origin; progression or recurrent disease; treatment
* [STRING]    `Anatomic_Site`
  - The text term used to describe the anatomic site of resection; biopsy; tissue or organ of biospecimen origin; progression or recurrent disease; treatment
* [STRING]    `Treatment_Anatomic_Site`
  - The text term used to describe the anatomic site of resection; biopsy; tissue or organ of biospecimen origin; progression or recurrent disease; treatment
* [STRING]    `entityId`
  - Synapse ID of entity
* [STRING]    `HTAN_Center`
  - Name of HTAN Center e.g. HTAN HTAPP
* [STRING]    `Data_Release`
  - Inclusion in HTAN Data Release e.g. Release 1.0
* [INT64]    `Manifest_Version`
  - Latest version of metadata manifest
* [STRING]    `Uuid`
  - Unique identifier of entity e.g. a96059eb-81af-4b24-ae50-9242c0d8f819

